Elucid Bioimaging
Boston, US · Delaware corporation · 2 known investors
Find your way into Elucid Bioimaging
221 people in our graph share verified history with the Elucid Bioimaging team — schools, employers, funds. One of them is your warm intro.
Teresa Chanunlockedknows Kelly Huang · together at Johnson & Johnson (overlapped)
×11knows the team · via Johnson & Johnson
Founders & leadership
BR
Blake RichardsExecutive
KH
Kelly HuanginExecutiveKelly Huang is Chief Executive Officer of Elucid Bioimaging, an AI-driven medical technology company focused on cardiovascular imaging. She has held CEO positions at public and private healthcare companies and serves as Managing Director at Spindletop Capital, an investment firm focused on healthcare innovation.
RB
Robert BraunNamed on SEC filing
Board
EM
Evan MelroseBoard director
RP
Rajesh PandaBoard director
ML
Michael LeshBoard director
RK
Richard KuntzBoard director
SF
Shamiram FeinglassBoard director
SH
Scott HuennekensBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$115.4M disclosed across 2 rounds · 2023–2025
▶$36.5MraisedOct 2025 · 9 investors · BiotechnologyRule 506(b)
▶$36.5MraisedOct 2025 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Evan MelroseDirector
- Michael LeshDirector
- Blake RichardsExecutive Officer
- Richard KuntzDirector
- Rajesh PandaDirector
- Kelly HuangExecutive Officer, Director
- Shamiram FeinglassDirector
- Scott HuennekensDirector
- Offering amount
- $80M
- Amount sold
- $36.5M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$79MraisedNov 2023 · 13 investors · BiotechnologyRule 506(b)
▶$79MraisedNov 2023 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert BraunDirector
- Scott HuennekensExecutive Officer, Director
- Michael LeshDirector
- Blake RichardsExecutive Officer, Director
- Evan MelroseDirector
- Offering amount
- $79M
- Amount sold
- $79M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Elucid Bioimaging's investors?
- Elucid Bioimaging's investors include BlueStone Venture Partners, MedTex Ventures LLC.
- How much funding has Elucid Bioimaging raised?
- Elucid Bioimaging has disclosed $115.4M raised across 2 rounds.
- Where is Elucid Bioimaging headquartered?
- Elucid Bioimaging is headquartered in Boston, US.